Zelboraf 240 mg – DIN 02380242
Zelboraf is Vemurafenib 240 mg (tablet), sold in Canada. It is used for melanoma. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Vemurafenib 240 mg
- Brand
- Zelboraf
- Strength
- 240 mg
- Used for
- Melanoma
- Form
- Tablet
- Manufacturer
- Hoffmann-LA Roche Limited
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02380242
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Vemurafenib used for?
Vemurafenib is used for melanoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Unresectable or Metastatic Melanoma
ZELBORAF ® is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
Limitation of Use: ZELBORAF is not indicated for treatment of patients with wild-type BRAF melanoma.
Erdheim-Chester Disease
ZELBORAF® is indicated for the treatment of patients with Erdheim-Chester Disease (ECD) with BRAF V600 mutation.
From the FDA-approved label on DailyMed (published Sep 04, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02380242.
- It names Zelboraf, Vemurafenib 240 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Zelboraf film-coated tablet by Hoffmann-LA Roche Limited.
In Canada: prescription only.
Ingredients
Active: Vemurafenib